報價延遲最少15分鐘:2026/04/26 08:32 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
18.7 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.41/1.54
|
|
企業價值
181.41M
|
| 資產負債 |
|
每股賬面淨值
0.19
|
| 現金流量 |
|
現金流量率
0.02
|
| 損益表 |
|
收益
44.05M
|
|
每股收益
0.09
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety ofacute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States. |
